MA50087A - Vésicules extracellulaires provenant de prevotella - Google Patents

Vésicules extracellulaires provenant de prevotella

Info

Publication number
MA50087A
MA50087A MA050087A MA50087A MA50087A MA 50087 A MA50087 A MA 50087A MA 050087 A MA050087 A MA 050087A MA 50087 A MA50087 A MA 50087A MA 50087 A MA50087 A MA 50087A
Authority
MA
Morocco
Prior art keywords
prevotella
extracellular vesicles
vesicles
extracellular
Prior art date
Application number
MA050087A
Other languages
English (en)
Inventor
Baundauna Bose
Will Caffry
Sofia M R Carlton
Christopher J H Davitt
Brian Goodman
Hank Wu
Original Assignee
Evelo Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evelo Biosciences Inc filed Critical Evelo Biosciences Inc
Publication of MA50087A publication Critical patent/MA50087A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10—Mechanical dissociation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Emergency Medicine (AREA)
MA050087A 2017-09-08 2018-09-10 Vésicules extracellulaires provenant de prevotella MA50087A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762556020P 2017-09-08 2017-09-08
US201862632859P 2018-02-20 2018-02-20
US201862668556P 2018-05-08 2018-05-08

Publications (1)

Publication Number Publication Date
MA50087A true MA50087A (fr) 2020-07-15

Family

ID=63832483

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050087A MA50087A (fr) 2017-09-08 2018-09-10 Vésicules extracellulaires provenant de prevotella

Country Status (12)

Country Link
US (2) US20190240263A1 (fr)
EP (1) EP3679057A1 (fr)
JP (2) JP2020533291A (fr)
KR (1) KR20200053532A (fr)
CN (1) CN111526881A (fr)
AU (1) AU2018330323A1 (fr)
BR (1) BR112020004347A2 (fr)
CA (1) CA3075270A1 (fr)
MA (1) MA50087A (fr)
MX (1) MX2020002660A (fr)
TW (1) TWI840334B (fr)
WO (1) WO2019051381A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016126831A1 (fr) 2015-02-03 2016-08-11 Mayo Foundation For Medical Education And Research Méthodes et matériels d'évaluation et de traitement de l'arthrite
IL265109B2 (en) 2016-09-13 2024-05-01 Allergan Inc Stabilized non-protein clostridial toxin compositions
CN111148531A (zh) 2017-09-08 2020-05-12 伊夫罗生物科学公司 细菌胞外囊泡
WO2019178601A1 (fr) 2018-03-16 2019-09-19 Zoetis Services Llc Vaccins peptidiques contre l'interleukine-31
EP3886881B1 (fr) * 2018-11-30 2025-07-16 Ospedale San Raffaele S.r.l. Souche de prevotella melaninogenica pour son utilisation contre le cancer ou le diabète
TW202045192A (zh) * 2019-02-22 2020-12-16 美商艾弗洛生物科技股份有限公司 細菌膜製劑
BR112021023169A2 (pt) * 2019-05-21 2022-01-04 Evelo Biosciences Inc Métodos e composições para fermentação bacteriana anaeróbica
WO2020252144A1 (fr) * 2019-06-11 2020-12-17 Evelo Biosciences, Inc. Vésicules extracellulaires microbiennes sécrétées
EP3983067A4 (fr) * 2019-06-17 2023-06-14 Mayo Foundation for Medical Education and Research Préparations de prevotella et traitement de la bronchopneumopathie chronique obstructive (bpco) et d'autres affections pulmonaires
CN114245742A (zh) * 2019-06-21 2022-03-25 伊夫罗生物科学公司 使用普雷沃菌属治疗th2介导的病症的组合物和方法
TW202120683A (zh) * 2019-08-02 2021-06-01 美商艾弗洛生物科技股份有限公司 用於培養血紅素依賴性細菌之方法及組成物
CN115515610A (zh) * 2019-08-05 2022-12-23 伊夫罗生物科学公司 使用栖组织普雷沃菌治疗银屑病和特应性皮炎的组合物和方法
KR20220121815A (ko) 2019-11-27 2022-09-01 에벨로 바이오사이언시즈, 인크. 헤모글로빈-의존성 박테리아를 배양하기 위한 방법 및 조성물
CN115551486A (zh) * 2020-04-17 2022-12-30 伊夫罗生物科学公司 具有改善的崩解谱的固体剂型
WO2022020364A1 (fr) 2020-07-21 2022-01-27 Evelo Biosciences, Inc. Souche c de prevotella histicola en tant que thérapie orale contre des maladies inflammatoires
WO2022051494A1 (fr) * 2020-09-03 2022-03-10 Evelo Biosciences, Inc. Compositions et méthodes de résolution d'inflammation
MX2023003089A (es) * 2020-09-18 2023-05-09 Evelo Biosciences Inc Formas farmaceuticas solidas de bacterias.
TW202227112A (zh) * 2020-09-21 2022-07-16 美商艾弗洛生物科技股份有限公司 使用棲組織普雷沃菌治療炎症之組成物及方法
WO2022061119A1 (fr) * 2020-09-21 2022-03-24 Evelo Biosciences, Inc. Compositions et méthodes pour moduler des réponses immunitaires avec prevotella histicola
WO2022092783A1 (fr) * 2020-10-27 2022-05-05 재단법인 아산사회복지재단 Application de la souche prevotella stercorea pour la prévention ou le traitement du cancer
US20240024377A1 (en) 2020-10-29 2024-01-25 Evelo Biosciences, Inc. Compositions comprising spirulina components
EP4267154A1 (fr) * 2020-12-22 2023-11-01 Evelo Biosciences, Inc. Compositions comprenant de l'hémoglobine animale
CN112611877B (zh) * 2020-12-31 2022-09-16 四川大学华西医院 一款利用angptl4预测急性呼吸窘迫综合征患病及预后的试剂盒
WO2022164806A1 (fr) * 2021-01-26 2022-08-04 Evelo Biosciences, Inc. Préparations de vésicules extracellulaires de prevotella
US20240148797A1 (en) * 2021-02-26 2024-05-09 Evelo Biosciences, Inc. Compositions and methods for reducing cytokine expression
WO2022187064A1 (fr) * 2021-03-01 2022-09-09 Evelo Biosciences, Inc. Compositions et procédés de traitement d'une inflammation à l'aide de prevotella histicola
WO2022251166A2 (fr) 2021-05-25 2022-12-01 Evelo Biosciences, Inc. Compositions bactériennes comprenant de l'hémoglobine de soja
CN113358872B (zh) * 2021-06-03 2022-10-21 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 用于评估肿瘤免疫治疗疗效的标志物组及系统
KR20230024502A (ko) 2021-08-12 2023-02-21 (주)프로스테믹스 miRNA를 포함하는 세포외 소포 및 이의 용도
CN113509494A (zh) * 2021-09-06 2021-10-19 南京医科大学 普氏菌在制备治疗胆汁淤积性疾病的药物中的应用
WO2023107537A1 (fr) 2021-12-07 2023-06-15 Evelo Biosciences, Inc. Compositions d'anticorps et procédés d'utilisation avec des vésicules extracellulaires et microbes
WO2023146843A1 (fr) * 2022-01-25 2023-08-03 Evelo Biosciences, Inc. Compositions de vésicules extracellulaires et méthodes d'utilisation
WO2023200837A1 (fr) * 2022-04-13 2023-10-19 Evelo Biosciences, Inc. Compositions et méthodes de traitement d'une inflammation à l'aide de prevotella histicola
US20250235433A1 (en) * 2022-04-19 2025-07-24 Cedars-Sinai Medical Center Methods of treating and diagnosing fatty liver disease
US20250325598A1 (en) * 2022-05-06 2025-10-23 The Regents Of The University Of Colorado, A Body Corporate Immunobiotics for preventing bacterial pneumonia and methods of using the same
WO2023239728A1 (fr) * 2022-06-07 2023-12-14 Evelo Biosciences, Inc. Compositions et méthodes de traitement d'une inflammation à l'aide de vésicules extracellulaires de prevotella histicola
WO2025076308A1 (fr) * 2023-10-06 2025-04-10 University Of Florida Research Foundation, Incorporated Compositions et méthodes pour analyser l'effet du microbiote sur la conformation des protéines hôtes et pour traiter des maladies neurodégénératives
CN117481145B (zh) * 2023-10-26 2024-05-10 湖北省生物农药工程研究中心 几丁质结合蛋白BvCBP及其复配物在制备植物害螨杀螨剂中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322784A (en) * 1991-06-05 1994-06-21 The Board Of Trustees Of The University Of Illinois, Urbana-Champaign, Illinois Method and materials for introducing DNA into Prevotella ruminicola
EP1261355B1 (fr) * 2000-03-01 2004-12-01 Société des Produits Nestlé S.A. Formulation de carbohydrate (adjuvant prebiotique) destine a augmenter une reponse immune
WO2011027971A2 (fr) * 2009-09-01 2011-03-10 주식회사이언메딕스 Vésicules extracellulaires dérivées de la flore intestinale, et procédé de recherche d'un modèle de maladie, d'un vaccin et d'un médicament candidat, et de diagnostic utilisant ce dernier
WO2011053653A2 (fr) * 2009-10-30 2011-05-05 Mayo Foundation For Medical Education And Research Préparations à base de prevotella histicola et traitement d'états auto-immuns
US9408880B2 (en) * 2013-12-20 2016-08-09 Katherine Rose Kovarik Method and system for prevention and treatment of allergic and inflammatory diseases
WO2012002760A2 (fr) * 2010-07-01 2012-01-05 포항공과대학교 산학협력단 Méthode de diagnostic et de traitement du cancer par des microvésicules cellulaires
US10137157B2 (en) * 2013-06-03 2018-11-27 Proprev Ab Treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimer's disease and inflammatory bowel disease by using at least one bacterial strain from Prevotella
KR101740893B1 (ko) * 2014-05-20 2017-06-13 주식회사 엠디헬스케어 Ａｋｋｅｒｍａｎｓｉａ ｍｕｃｉｎｉｐｈｉｌａ 균에서 유래하는 세포밖 소포를 유효성분으로 함유하는 대사질환의 치료 또는 예방용 조성물
US10722543B2 (en) * 2016-01-28 2020-07-28 Oxyrase, Inc. Methods for inhibiting tumor growth using anaerobe microorganisms

Also Published As

Publication number Publication date
JP2020533291A (ja) 2020-11-19
EP3679057A1 (fr) 2020-07-15
KR20200053532A (ko) 2020-05-18
JP2023153808A (ja) 2023-10-18
AU2018330323A1 (en) 2020-03-19
CN111526881A (zh) 2020-08-11
US20190240263A1 (en) 2019-08-08
US20230405058A1 (en) 2023-12-21
CA3075270A1 (fr) 2019-03-14
WO2019051381A1 (fr) 2019-03-14
MX2020002660A (es) 2020-07-22
TW201920652A (zh) 2019-06-01
TWI840334B (zh) 2024-05-01
BR112020004347A2 (pt) 2020-09-08

Similar Documents

Publication Publication Date Title
IL277344A (en) Extracellular vesicles containing agonist-STING
MA50086A (fr) Vésicules extracellulaires (ev) bactériennes
EP3718983A4 (fr) Pare-brise
MA49549A (fr) Auto-injecteur
EP3602422A4 (fr) Apprentissage-machine de protection de la vie privée
EP3690389A4 (fr) Jauge de contrainte
EP3602439A4 (fr) Techniques de livraison supervisée
EP3604005A4 (fr) Pare-brise
EP3852770A4 (fr) Vésicules extracellulaires modifiées en surface
IL280658A (en) Extracellular vesicles for inhalation
EP3521427A4 (fr) Co-récepteur de récepteur odorant
UA32259S (uk) Розприскувач
EP3689999A4 (fr) Pulvérisateur
EP3580180C0 (fr) Système de dispersion de saumure
EP3898218C0 (fr) Produit en papier mousseline
IL280851A (en) Targeted extracellular vesicles
EP3429558C0 (fr) Polymersomes de fumarate
EP3733623A4 (fr) Pare-brise
EP3554717C0 (fr) Appareil de pulvérisation
DK3469445T3 (da) Termoelektrisk generator
DK3642475T3 (da) Hvirvelgenerator
DK3395738T3 (da) Dispenser
EP3577882C0 (fr) Visibilité de réseau
EP3621875A4 (fr) Véhicule aérien
EP3438473A4 (fr) Structure de raccord